Topical lidocaine for the treatment of postherpetic neuralgia: Cochrane systematic review
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Topical Lidocaine for the Treatment of Postherpetic Neuralgia: Cochrane Systematic Review." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431055/all/Interventions_for_varicose_veins_and_leg_oedema_in_pregnancy_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
Topical lidocaine for the treatment of postherpetic neuralgia: Cochrane systematic review. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431055/all/Interventions_for_varicose_veins_and_leg_oedema_in_pregnancy_New_search_for_studies_and_content_updated__no_change_to_conclusions_. Accessed February 16, 2025.
Topical lidocaine for the treatment of postherpetic neuralgia: Cochrane systematic review. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431055/all/Interventions_for_varicose_veins_and_leg_oedema_in_pregnancy_New_search_for_studies_and_content_updated__no_change_to_conclusions_
Topical Lidocaine for the Treatment of Postherpetic Neuralgia: Cochrane Systematic Review [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 February 16]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431055/all/Interventions_for_varicose_veins_and_leg_oedema_in_pregnancy_New_search_for_studies_and_content_updated__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Topical lidocaine for the treatment of postherpetic neuralgia: Cochrane systematic review
ID - 431055
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431055/all/Interventions_for_varicose_veins_and_leg_oedema_in_pregnancy_New_search_for_studies_and_content_updated__no_change_to_conclusions_
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -